| __timestamp | Amgen Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 855506000 |
| Thursday, January 1, 2015 | 4070000000 | 996170000 |
| Friday, January 1, 2016 | 3840000000 | 1047690000 |
| Sunday, January 1, 2017 | 3562000000 | 1324625000 |
| Monday, January 1, 2018 | 3737000000 | 1416476000 |
| Tuesday, January 1, 2019 | 4116000000 | 1754540000 |
| Wednesday, January 1, 2020 | 4207000000 | 1829537000 |
| Friday, January 1, 2021 | 4819000000 | 3051100000 |
| Saturday, January 1, 2022 | 4434000000 | 2540300000 |
| Sunday, January 1, 2023 | 4784000000 | 3162900000 |
| Monday, January 1, 2024 | 5964000000 | 3630300000 |
Data in motion
In the competitive world of biotechnology, innovation is key. Amgen Inc. and Vertex Pharmaceuticals Incorporated are two giants in this field, each with a unique approach to research and development (R&D). Over the past decade, Amgen has consistently outpaced Vertex in R&D spending, investing nearly 2.3 times more on average. From 2014 to 2023, Amgen's R&D expenses grew by approximately 11%, peaking in 2021 with a 15% increase from the previous year. Meanwhile, Vertex has shown a remarkable growth trajectory, with R&D expenses increasing by over 270% during the same period, reflecting its aggressive push into new therapeutic areas. In 2023, Vertex's R&D spending reached its highest, closing the gap with Amgen. This trend highlights Vertex's commitment to innovation, positioning it as a formidable competitor in the biotech industry. As these companies continue to invest in groundbreaking research, the future of healthcare looks promising.
Eli Lilly and Company or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: Amgen Inc. and Exelixis, Inc.
R&D Insights: How Amgen Inc. and Pharming Group N.V. Allocate Funds
Research and Development Expenses Breakdown: Amgen Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs GSK plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Summit Therapeutics Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Verona Pharma plc
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs CymaBay Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated or Dynavax Technologies Corporation: Who Invests More in Innovation?